AzTrials
AzTrials

Laparoscopic CholecystectomyNCT06588777

Ultrasound Guided Modified Thoracoabdominal Nerve Block Through Perichondrial Approach (M-TAPA) Versus Quadratus Lumborum Block for Postoperative Analgesia in Laparoscopic Cholecystectomy

A study testing Modified thoracoabdominal nerve block through perichondrial approach (M-TAPA) and Quadratus lumborum block in people with Laparoscopic Cholecystectomy and Modified Thoracoabdominal Nerve Block, run by Ain Shams University at 1 site in Egypt.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

This study aims to compare the efficacy of using Ultrasound guided modified thoracoabdominal nerve block through perichondrial approach (M-TAPA) versus quadratus lumborum block for postoperative analgesia in laparoscopic cholecystectomy under general anesthesia. Read more about this study

Who is it for?
Ages 21 to 71 years
What is being tested?
Modified thoracoabdominal nerve block through perichondrial approach (M-TAPA) and Quadratus lumborum block
Could I receive a placebo?
No, everyone receives an active treatment
How many people
52 participants
Where
1 siteEgypt
Study dates
1 Sep 2024to 30 Dec 2025
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 21 to 71 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Adult patients aging ≥ 21 years to ≤ 70 of both sexes.
  • Patients undergoing Laparoscopic cholecystectomy surgeries.
  • ASA physical status classes I - II.

Who cannot join

  • Patient's refusal of procedure or participation in the study.
  • ASA classes III or above.
  • Coagulopathy and bleeding disorders.
  • Evidence of Local skin infections at site of injection.
  • Body mass index >40kg/m2
  • A history of relevant local anesthetic allergy.

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Ahmed Hassan, Master contact

01158195158

ahmedhassan199466@gmail.com

Egypt1 site, 1 recruiting
  • Ainshams university hospitals

    Cairo

    Ainshams

    Recruiting

Other trials in Egypt

About this study

This study aims to compare the efficacy of using Ultrasound guided modified thoracoabdominal nerve block through perichondrial approach (M-TAPA) versus quadratus lumborum block for postoperative analgesia in laparoscopic cholecystectomy under general anesthesia.

Being tested
Modified thoracoabdominal nerve block through perichondrial approach (M-TAPA), Quadratus lumborum block
Keywords
Laparoscopic cholecystectomy, modified thoracoabdominal nerve block, quadratus lumborum block

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Modified thoracoabdominal nerve block through perichondrial approach (M-TAPA)Procedure or surgery

    Also called (M-TAPA)

    transversus abdominis, internal oblique, and external oblique muscles will be identified with a high-frequency (10 MHz) linear probe on the costochondral angle in the sagittal plane under ultrasound guidance at the 10th costal margin. A deep angle was given to the costochondral angle at the edge of the 10th costal margin with the probe in the sagittal direction to view the lower surface of the costal cartilage in the midline. A 22-G, 100-mm block needle will be inserted in the cranial direction using the in-plane technique and the needle tip will be moved to the posterior aspect of the 10th costal cartilage. It is noted that the needle tip never crossed the cranial edge of the 10th costal cartilage

  • Quadratus lumborum blockProcedure or surgery

    Also called (QLB)

    using ultrasound guidance (Sonosite turbo M, Bothell, Washington, USA) and a curved ultrasound probe (2.5-7.5 MHz). The probe will be placed in the mid-axillary line between the lower costal margin and the iliac crest in a transverse plane to view all abdominal layers. The probe will be moved towards the posterior axillary line, to reach a point where all three abdominal muscle layers merge to form aponeurosis.

    The aponeurosis will then be followed dorsally until the quadratus lumborum muscle is seen deep to transversalis fascia with its attachment to the transverse process of the L4 vertebral body. A 22 G, 100 mm, blunt, insulated nerve block needle will be inserted 1 cm medial to the probe and advanced using the in-plane technique with ultrasound real-time assessment. The injection site will be the junction of transversalis fascia and the anterolateral border of quadratus lumborum muscle

Study groups in NCT06588777
Study groupRoleWhat they receive
Modified thoracoabdominal nerve block through perichondrial approach (M-TAPA)ExperimentalUsing the in plane technique A deep angle was given to the costochondral angle at the edge of the 10th costal margin with the probe in the sagittal direction to view the lower surface of the costal cartilage in the midline. A 22-G, 100-mm block needle will be inserted in the cranial direction using the in-plane technique and the needle tip will be moved to the posterior aspect of the 10th costal cartilage. It is noted that the needle tip never crossed the cranial edge of the 10th costal cartilage and 20 mL of 0.25% bupivacaine will be injected into the lower surface of the chondrium to make Modified thoracoabdominal nerve block through perichondrial approach (M-TAPA).
Receives: Procedure: Modified thoracoabdominal nerve block through perichondrial approach (M-TAPA)
Quadratus lumborum blockExperimentalUsing the in plane technique the probe will be placed in the mid-axillary line between the lower costal margin and the iliac crest in a transverse plane to view all abdominal layers. The probe will be moved towards the posterior axillary line, to reach a point where all three abdominal muscle layers merge to form aponeurosis. The aponeurosis will then be followed dorsally until the quadratus lumborum muscle is seen deep to transversalis fascia with its attachment to the transverse process of the L4 vertebral body. A 22 G, 100 mm, blunt, insulated nerve block needle will be inserted 1 cm medial to the probe and advanced using the in-plane technique with ultrasound real-time assessment. The injection site will be the junction of transversalis fascia and the anterolateral border of quadratus lumborum muscle.
Receives: Procedure: Quadratus lumborum block

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Time to first Rescue Analgesia

    Is to measure the first time to resque analgesia postoperative (24 hours)

    Measured: 24 hours postoperative

Secondary outcomes (4)
  1. The total requirements of rescue analgesia Meperidine (pethidine) over the first 24 hours postoperative

    Measured: 24 hours postoperative

  2. Heart rate

    Measured: at intervals of 0 (PACU), 1, 2, 4, 6, 12, 18 and 24 hours postoperatively

  3. Blood pressure

    Measured: at intervals of 0 (PACU), 1, 2, 4, 6, 12, 18 and 24 hours postoperatively

  4. Spo2 measuring

    Measured: at intervals of 0 (PACU), 1, 2, 4, 6, 12, 18 and 24 hours postoperatively

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted19 Sep 2024
  2. Study start1 Sep 2024
  3. Primary completion30 Dec 2025 (estimated)
  4. Study completion30 Dec 2025 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Participant
Enrolment
52 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06588777
Sponsor's protocol ID
MD92/2024
Status last verified
Sep 2025
First submitted
1 Sep 2024
Last updated
30 Sep 2025
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing Modified thoracoabdominal nerve block through perichondrial approach (M-TAPA) and Quadratus lumborum block in people with Laparoscopic Cholecystectomy and Modified Thoracoabdominal Nerve Block, run by Ain Shams University at 1 site in Egypt.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 30 Sep 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Ahmed Hassan, Master (01158195158, ahmedhassan199466@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Time to first Rescue Analgesia (time frame: 24 hours postoperative). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 30 Sep 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in